| abstract |
This invention is concerned with compounds of the formula (I) wherein one of R5, R6 and R7 is (a) and X1, X2, R1 to R15 and n are as defined in the description, and pharmaceutically acceptable salts and/or esters thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPARĪ“ and/or PPARĪ± agonists. |